Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
Incyte Corporation
M.D. Anderson Cancer Center
Xencor, Inc.
Incyte Corporation
Duke University